OTC - ACTIVE INGREDIENT SECTION
CAFFEINE
BUTYROSPERMUM PARKII (SHEA) BUTTER UNSAPONIFIABLES
VANILLYL BUTYL ETHER
CAFFEINE
BUTYROSPERMUM PARKII (SHEA) BUTTER UNSAPONIFIABLES
VANILLYL BUTYL ETHER
Promotes heat generation during exercise.
[Firming Cream]:Apply hot jelly to the affected areas twice daily. it will be absorbed into the skin. The ingredients start breaking down the fat cells, leaving a supple and more toned skin.
[For Muscle Relaxation]: Apply liberally to tight muscles. Avoid eyes and mucus membranes. Wash your hands after application.
For external use only.
Stop use and ask a doctor if rash occurs.
Do not use on damaged or broken skin.
When using this product keep out of eyes. Rinse with water to remove.
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
[Firming Cream]:Apply hot jelly to the affected areas twice daily. it will be absorbed into the skin. The ingredients start breaking down the fat cells, leaving a supple and more toned skin.
[For Muscle Relaxation]: Apply liberally to tight muscles. Avoid eyes and mucus membranes. Wash your hands after application.
ALLANTOIN
ACID YELLOW 9
PEG-100 STEARATE
GLYCERYL STEARATE SE
CENTELLAASIATICA
MENTHA X ROTUNDIFOLA LEAF
ALOE VERA LEAF
GLYCERIN
PEG-9 DIGLYCIDYL ETHERISODIUM HYALURONATE CROSSPOLYMER
BISABOLOL OXIDE A
1.2-HEXANEDIOL
WATER
HUMAN TYPE ICOLLAGEN (PLACENTA)HYDROXYACETOPHENONE
HYDRANGEA MACROPHYLLA LEAF
PORTULACA OLERACEA WHOLE
CARBOMER 980
CHRYSANTHELLUM INDICUM WHOLE
ACID YELLOW 11
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 83566-029 | 83566-029-01 |
Every source-derived ingredient row is available through these pages.
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 39f769ce-83e1-399f-e063-6294a90ae9d4 | 1b131751-2a56-df8d-e063-6394a90a0fb4 | 2025-07-15 | Warnings | 1b131751-2a56-df8d-e063-6394a90a0fb4 |
Adverse event summaries are temporarily unavailable. Other product information remains available.